07:00 , Jun 25, 2009 |  BC Innovations  |  Targets & Mechanisms

Seeing CNV sooner

New research by a multinational team suggests that noninvasive imaging of CC chemokine receptor 3 could help detect wet age-related macular degeneration before retinal damage occurs. 1 This would allow earlier therapeutic intervention, which is...
07:00 , Jun 18, 2009 |  BC Innovations  |  Distillery Therapeutics

Indication: Ophthalmic disease

Indication Target/marker/ pathway Summary Licensing status Publication and contact information Ophthalmic disease Age-related macular degeneration (AMD) CC chemokine receptor 3 (CCR3); eotaxin-1 (CCL11); eotaxin-2 (CCL24); eotaxin-3 (CCL26) Studies in human tissues and in mice suggest...